Heteroarylcarboxylic acid ester derivative
US8609715B2 · kind B2 · utility
5Cited by
1References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 31, 2012 |
| Grant date | Dec 17, 2013 |
| Priority date | — |
| Expiry date | May 31, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/65515
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds represented by formula (I):wherein each symbol is as defined in the description, and pharmaceutically acceptable salts thereof are useful as hyperglycemic inhibitors having a serine protease inhibitory action and as prophylactic or therapeutic drugs for diabetes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.